Quick Answer
NUTRA PHARMA CORP reported R&D Expense of $3.0 thousand for fiscal year 2012.
NUTRA PHARMA CORP R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2012 | $3.0K | -96.6% |
| 2011 | $90.9K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2011 | $17.3K | -1.7% | -71.9% |
| June 30, 2011 | $61.5K | -40.0% | +250.2% |
| September 30, 2010 | $17.6K | — | -82.9% |
| June 30, 2010 | $102.4K | — | — |
- NUTRA PHARMA CORP showed a decrease of -96.6% in R&D Expense compared to the prior fiscal year.
- Over the 2011–2012 period, NUTRA PHARMA CORP’s r&d expense has declined by 96.6% (from $90.9 thousand to $3.0 thousand).
- The most recent figure is from NUTRA PHARMA CORP’s fiscal year 2012 report (Form 10-K), filed with the SEC on April 16, 2013.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: